Tenecteplase improved functional outcomes without added safety risk in selected basilar artery occlusion stroke treated up to 24 hours after onset in the TRACE-5 trial.

A new trial suggests the optimal approach for basilar artery occlusion stroke may vary depending on whether the blockage stems from embolism or intracranial atherosclerosis.

May 6, 2022 · The benefit of endovascular therapy in the treatment of stroke caused by an occlusion of the basilar artery has finally been confirmed in the ATTENTION randomized controlled trial.

May 11, 2022 · The BAOCHE trial has shown a large benefit of endovascular thrombectomy for patients with a stroke caused by a basilar artery occlusion.

Vertebral artery stenting will be justified if these studies demonstrate substantial benefits of endovascular revascularization to medical management for patients with symptomatic vertebral artery ...

Oct 31, 2022 · In addition, she said Womack failed to rule out a vertebral artery dissection and that Waldschmidt did not " [appreciate] an indisputable acute or subacute vertebral-basilar artery occlusion."

Sep 8, 2016 · Outcomes in stroke patients with acute basilar artery occlusion who are given intra-arterial treatment have improved significantly in recent years, reflecting important advances over outcomes ...

Feb 21, 2020 · The addition of endovascular therapy to thrombolysis for acute ischemic stroke with basilar artery occlusion improved functional outcomes in a new registry study.

Jan 29, 2025 · A new advisory from the American Heart Association strongly endorses endovascular treatment for patients with large core ischemic stroke.

Oct 30, 2025 · Tenecteplase Benefits Basilar Artery Stroke Out to 24 Hours Medscape Medical News, November 3, 2025 Clear Benefit of Thrombectomy in Large-Core Stroke Medscape Medical News, …